Reported 262,786 shares, unchanged from the prior quarter.
Reported value 18.3%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-03-31 | 4441000 |
| 2022-06-30 | 2126000 |
| 2022-09-30 | 2515000 |
| 2022-12-31 | 2961598 |
| 2023-03-31 | 1187793 |
| 2023-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | Reduced | 0 | -262,786 (-100.0%) | 0 | $0 | 2023-08-14 | |
| Q1 2023 | Unchanged | 262,786 | 0 (0.0%) | 0.25% | $1,187,793 | 2023-05-15 | |
| Q4 2022 | Unchanged | 262,786 | 0 (0.0%) | 0.64% | $2,961,598 | 2023-02-14 | |
| Q3 2022 | Unchanged | 262,786 | 0 (0.0%) | 0.59% | $2,515,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 262,786 | 0 (0.0%) | 0.57% | $2,126,000 | 2022-08-15 | |
| Q1 2022 | New | 262,786 | +262,786 (0.0%) | 1.12% | $4,441,000 | 2022-05-16 |
Who else reported the position
110 managers reported ALX ONCOLOGY HLDGS INC for Q3 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| venBio Partners LLC | Unchanged | 9,699,925 | 0 | 21.48% | $92,828,000 | 9 qtrs |
| FMR LLC | Added | 4,630,574 | +644,360 | < 0.01% | $44,315,000 | 9 qtrs |
| Vivo Capital LLC | Unchanged | 4,220,048 | 0 | 4.46% | $40,386,000 | 9 qtrs |
| Logos Global Management LP | Reduced | 2,971,352 | -165,000 | 3.5% | $28,436,000 | 9 qtrs |
| ORBIMED ADVISORS LLC | Added | 2,871,000 | +684,731 | 0.52% | $27,475,000 | 8 qtrs |
| BlackRock Inc | Added | 1,670,402 | +8,120 | < 0.01% | $15,987,000 | 9 qtrs |
| VANGUARD GROUP INC | Added | 1,411,009 | +86,272 | < 0.01% | $13,503,000 | 9 qtrs |
| EVENTIDE ASSET MANAGEMENT LLC | New | 902,000 | +902,000 | 0.17% | $8,632,000 | 1 qtr |
| Redmile Group LLC | Reduced | 752,097 | -14,700 | 0.28% | $7,198,000 | 9 qtrs |
| Cormorant Asset Management LP | Unchanged | 712,079 | 0 | 0.48% | $6,815,000 | 9 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2022
- Filed
- November 14, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 262,786
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.